{"id":"metronidazole-250-7-days","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Metallic taste"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"1-2","effect":"Peripheral neuropathy"},{"rate":"5-10","effect":"Darkened urine"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is a prodrug that is activated by anaerobic organisms and parasites to form reactive intermediates that bind to and cleave DNA, preventing replication and transcription. It is effective against anaerobic bacteria and certain protozoan parasites. The drug is bactericidal and antiprotozoal, making it useful for infections caused by these organisms.","oneSentence":"Metronidazole disrupts bacterial and parasitic DNA by generating reactive oxygen species and damaging their genetic material.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:34:32.663Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections"},{"name":"Trichomoniasis"},{"name":"Amebiasis"},{"name":"Giardiasis"},{"name":"Bacterial vaginosis"},{"name":"Clostridioides difficile infection"},{"name":"Anaerobic abdominal and pelvic infections"}]},"trialDetails":[{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT01330719","phase":"NA","title":"Mechanisms and Treatment Response of Aggressive Periodontitis in Children","status":"COMPLETED","sponsor":"University of Florida","startDate":"2006-12","conditions":"Aggressive Periodontitis","enrollment":514},{"nctId":"NCT03779074","phase":"PHASE3","title":"Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2018-09-03","conditions":"Helicobacter Pylori Infection","enrollment":918},{"nctId":"NCT03458663","phase":"NA","title":"Randomized Trial Comparing Prevena and ActiV.A.C. System to Convetional Care After Bascom's Cleft Lift Surgery","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2019-01-14","conditions":"Pilonidal Disease","enrollment":106},{"nctId":"NCT04580355","phase":"PHASE4","title":"Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome","status":"UNKNOWN","sponsor":"University of Campinas, Brazil","startDate":"2021-07","conditions":"Microbial Colonization, Periodontal Diseases, Periodontal Inflammation","enrollment":30},{"nctId":"NCT03564301","phase":"PHASE4","title":"Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"Juan Blanco Carrión","startDate":"2018-03-03","conditions":"Peri-Implantitis","enrollment":20},{"nctId":"NCT03079388","phase":"NA","title":"Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-02-27","conditions":"Pregnancy, Malnutrition in Pregnancy, Nutrition Disorders","enrollment":1489},{"nctId":"NCT02646332","phase":"NA","title":"Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2015-12","conditions":"Helicobacter Pylori Infection","enrollment":248},{"nctId":"NCT03374176","phase":"PHASE3","title":"Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes","status":"COMPLETED","sponsor":"Centro Universitario de Tonalá","startDate":"2014-03","conditions":"Periodontitis, Periodontal Pocket, Diabetes Mellitus","enrollment":42},{"nctId":"NCT02735395","phase":"PHASE4","title":"Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis","enrollment":110},{"nctId":"NCT04066257","phase":"PHASE1","title":"Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2019-01-17","conditions":"Healthy","enrollment":32},{"nctId":"NCT02547038","phase":"NA","title":"Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2015-02","conditions":"Helicobacter Pylori Infection","enrollment":352},{"nctId":"NCT03933501","phase":"PHASE4","title":"Amoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2006-01-01","conditions":"Generalized Aggressive Periodontitis","enrollment":48},{"nctId":"NCT03219723","phase":"","title":"Drug Use Surveillance of Takecab for \"Supplement to Helicobacter Pylori Eradication\"","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-09-01","conditions":"Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other","enrollment":560},{"nctId":"NCT03727620","phase":"PHASE1, PHASE2","title":"Doxycycline in the Treatment of Aggressive Periodontitis","status":"COMPLETED","sponsor":"Mohammed V Souissi University","startDate":"2014-01-06","conditions":"Aggressive Periodontitis","enrollment":24},{"nctId":"NCT02541864","phase":"NA","title":"Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2013-07","conditions":"Helicobacter Pylori Infection","enrollment":330},{"nctId":"NCT01725906","phase":"PHASE4","title":"Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-11","conditions":"Self Efficacy","enrollment":450},{"nctId":"NCT01264822","phase":"","title":"Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-01-13","conditions":"Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive","enrollment":108},{"nctId":"NCT02334163","phase":"PHASE2","title":"The Effects of Nitazoxanide in Hepatic Encephalopathy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2014-12","conditions":"Hepatic Encephalopathy","enrollment":36},{"nctId":"NCT01163435","phase":"PHASE4","title":"Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2010-08","conditions":"Helicobacter Infection","enrollment":618},{"nctId":"NCT01841411","phase":"PHASE4","title":"Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Minia University","startDate":"2013-03","conditions":"Bacterial Vaginosis","enrollment":90},{"nctId":"NCT00066066","phase":"PHASE2","title":"Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers","status":"COMPLETED","sponsor":"The Forsyth Institute","startDate":"2003-07","conditions":"Periodontitis, Periodontal Diseases","enrollment":146},{"nctId":"NCT01046435","phase":"NA","title":"Effects of Periodontal Therapy on Systemic Inflammation","status":"COMPLETED","sponsor":"University of Chile","startDate":"2007-03","conditions":"Periodontal Disease, Cardiovascular Disease, Type 2 Diabetes","enrollment":186}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Metronidazole 250 (7 days)","genericName":"Metronidazole 250 (7 days)","companyName":"University of Guarulhos","companyId":"university-of-guarulhos","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole disrupts bacterial and parasitic DNA by generating reactive oxygen species and damaging their genetic material. Used for Anaerobic bacterial infections, Trichomoniasis, Giardiasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}